The global intracranial pressure (ICP) monitoring devices market is projected to show a significant growth rate. The increase in traumatic brain injuries due to accidents increased the usage of ICP monitoring devices for brain monitoring. Technological advancement in the ICP monitoring devices is anticipated to drive the market growth. The technological advancement in ICP monitoring devices includes the integration of the rechargeable battery, wireless technology, USB connectivity and watertight construction for having a precise and accurate measurement of intracranial pressure. New product development strategy is the core strength of major market players to have a competitive edge over their competitors. Moreover, as R&D for product development requires a huge capital expenditure the key players are rapidly adopting growth strategies such as mergers, collaboration, and partnerships to strengthen their revenue.
Browse the full report description of Global Intracranial Pressure (ICP) Monitoring Devices Market Size, Share & Trends Analysis Report, by Technique (Invasive Monitoring Devices, and Non- Invasive Monitoring Devices), by Application (Intracerebral Hemorrhage, Meningitis, Traumatic Brain Injury, and Others), Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/intracranial-pressure-monitoring-devices-market
Recent Developments
- In April 2019, Integra LifeSciences had launched the CereLink Intracranial Pressure Monitoring system. This advanced technology facilitates neurocritical care teams to have more accuracy in terms of less drift over time. Moreover, it offers more protection due to MR conditional capability, more alternative due to high durability, flexible ICP sensors, and more information due to its advanced data presentation than the previously available ICP monitoring technologies.
Recent Activities
- In October 2017, Integra LifeSciences had acquired Johnson & Johnson Codman Neurosurgery Business. This acquisition was done to increase the product portfolio of Integra Life Science in the neurosurgery segment. By this acquisition, the company will have access to Codman's DURAFORM, standard EVD catheters, and CFS collection systems.
- In September 2017, Natus Medical, Inc. had acquired certain neurosurgery business assets from Integra LifeSciences Corp. This acquisition was done by Natus to expand its market presence by entering into the neurosurgery market which is an adjacent market to its neurodiagnostic business. This expansion will strengthen the market position of Natus in the neurology segment.
Current market Trends covered in the Market Report
- Traumatic Brain Injuries- Major application of ICP monitoring devices.
- North America held a major market share.
- Growth in the number of patients suffering from neurological disorders.
- Asia-Pacific to show a significant growth rate.
- The rapid paradigm shift from invasive monitoring devices to non-invasive monitoring devices.
- Companies are making large investments in R&D for the development of technically advanced ICP monitoring devices.
- Increase in prevalence of chronic diseases such as diabetes, high blood pressure, and others.
Intracranial Pressure (ICP) Monitoring Devices Market Segmentation
By Technique
- Invasive Monitoring Devices
- Non-Invasive Monitoring Devices
By Application
- Intracerebral Haemorrhage
- Meningitis
- Subarachnoid Haemorrhage
- Traumatic Brain Injury
- Others
Intracranial Pressure (ICP) Monitoring Devices Market – Segment by Region
North America
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/intracranial-pressure-monitoring-devices-market